CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: benzalkonium chloride
Accession: CHEBI:3020
browse the term
Definition: A class of quaternary ammonium chloride salts in which the nitrogen is substituted by a benzyl group, two methyl groups and an even-numbered alkyl chain.
Synonyms: related_synonym: ADBAC; Alkyl dimethylbenzyl ammonium chloride; Alkylbenzyldimethylammonium chloride; Alkyldimethyl(phenylmethyl)quaternary ammonium chlorides; Alkyldimethylbenzylammonium chloride; benzalkonii chloridum; benzalkonium chlorides; chlorure de benzalkonium; cloruro de benzalconio
alt_id: MESH:D001548
xref: CAS:8001-54-5
xref_mesh: MESH:D001548
xref: kegg.compound:C08037; kegg.drug:D00857; pubmed:17660979; pubmed:22692451; pubmed:23078159; pubmed:23102555; pubmed:23278376; pubmed:23439005; pubmed:23519403; pubmed:23542350; pubmed:23651563; pubmed:23682619; pubmed:23726247; pubmed:23792171; pubmed:23861389; pubmed:23892748; pubmed:23893017; pubmed:23987445; pubmed:23987991; pubmed:23991114; pubmed:7526642
chemrof_smiles: *[N+](C)(C)Cc1ccccc1.[Cl-]
chemrof_formula: C9H13ClNR
G
Aacs
acetoacetyl-CoA synthetase
increases expression
ISO
Benzalkonium Compounds results in increased expression of AACS mRNA
CTD
PMID:31199489
NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543
G
Abca1
ATP binding cassette subfamily A member 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ABCA1 mRNA
CTD
PMID:26919959
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
G
Abca12
ATP binding cassette subfamily A member 12
increases expression
ISO
Benzalkonium Compounds results in increased expression of ABCA12 mRNA
CTD
PMID:25377654
NCBI chr 9:80,272,121...80,445,340
Ensembl chr 9:80,272,127...80,445,340
G
Abca6
ATP binding cassette subfamily A member 6
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ABCA6 mRNA
CTD
PMID:20713136
NCBI chr10:95,642,026...95,711,535
Ensembl chr10:95,641,900...95,710,899
G
Acod1
aconitate decarboxylase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ACOD1 mRNA
CTD
PMID:30171875
NCBI chr15:86,286,531...86,295,803
Ensembl chr15:86,286,579...86,295,687
G
Acp6
acid phosphatase 6, lysophosphatidic
increases expression
ISO
Benzalkonium Compounds results in increased expression of ACP6 mRNA
CTD
PMID:31199489
NCBI chr 2:187,400,786...187,421,877
Ensembl chr 2:187,349,186...187,422,743
G
Acsl4
acyl-CoA synthetase long-chain family member 4
increases expression
ISO
Benzalkonium Compounds results in increased expression of ACSL4 mRNA
CTD
PMID:31199489
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
G
Ada
adenosine deaminase
increases expression
ISO
Benzalkonium Compounds results in increased expression of ADA mRNA
CTD
PMID:30171875
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ADH1 mRNA
CTD
PMID:31199489
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291
G
Adora1
adenosine A1 receptor
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ADORA1 mRNA
CTD
PMID:30171875
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
G
Adra2a
adrenoceptor alpha 2A
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of ADRA2A mRNA
CTD
PMID:30171875
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:263,065,278...263,069,871
G
Agtr2
angiotensin II receptor, type 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of AGTR2 mRNA
CTD
PMID:30171875
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:116,913,656...116,918,745
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Benzalkonium Compounds results in increased expression of AKR1B10 mRNA
CTD
PMID:30806763
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847
G
Alb
albumin
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ALB mRNA
CTD
PMID:31199489
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
G
Amigo2
adhesion molecule with Ig like domain 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of AMIGO2 mRNA
CTD
PMID:37149095
NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218
G
Apoa1
apolipoprotein A1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of APOA1 mRNA
CTD
PMID:31199489
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729
G
Apoa2
apolipoprotein A2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of APOA2 mRNA
CTD
PMID:31199489
NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410
G
Apoc1
apolipoprotein C1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of APOC1 mRNA
CTD
PMID:31199489
NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:88,474,663...88,478,155
G
Aqp3
aquaporin 3 (Gill blood group)
increases expression
ISO
Benzalkonium Compounds results in increased expression of AQP3 mRNA
CTD
PMID:30171875
NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685
G
Areg
amphiregulin
increases expression
ISO
Benzalkonium Compounds results in increased expression of AREG mRNA
CTD
PMID:30171875
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641
G
Arg2
arginase 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of ARG2 mRNA
CTD
PMID:30171875
NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375
G
Art3
ADP-ribosyltransferase 3
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ART3 mRNA
CTD
PMID:31199489
NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806
G
Atf4
activating transcription factor 4
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ATF4 mRNA
CTD
PMID:28236482
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
G
Atp5f1e
ATP synthase F1 subunit epsilon
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ATP5F1E mRNA
CTD
PMID:31199489
NCBI chr 3:183,677,270...183,680,172
Ensembl chr 3:183,677,273...183,680,214
G
Atp5mg
ATP synthase membrane subunit G
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ATP5MG mRNA
CTD
PMID:31199489
NCBI chr 8:54,122,457...54,130,407
Ensembl chr 8:54,122,457...54,132,831
G
B3galt4
Beta-1,3-galactosyltransferase 4
affects response to substance
ISO
B3GALT4 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,937,974...4,939,549
Ensembl chr20:4,937,674...4,939,885
G
Bambi
BMP and activin membrane-bound inhibitor
increases expression
ISO
Benzalkonium Compounds results in increased expression of BAMBI mRNA
CTD
PMID:20146380
NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247
G
Bcl3
BCL3, transcription coactivator
increases expression
ISO
Benzalkonium Compounds results in increased expression of BCL3 mRNA
CTD
PMID:30171875
NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368
G
Btc
betacellulin
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of BTC mRNA
CTD
PMID:30171875
NCBI chr14:16,992,668...17,031,178
Ensembl chr14:16,992,193...17,033,078
G
C3
complement C3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of C3 mRNA
CTD
PMID:30171875
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
G
Casp3
caspase 3
increases cleavage multiple interactions
ISO
Benzalkonium Compounds analog results in increased cleavage of CASP3 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Benzalkonium Compounds analog results in increased cleavage of CASP3 protein]
CTD
PMID:31982400
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp8
caspase 8
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CASP8 mRNA
CTD
PMID:28236482
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
G
Ccl11
C-C motif chemokine ligand 11
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCL11 protein
CTD
PMID:30517752
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575
G
Ccl2
C-C motif chemokine ligand 2
increases expression increases secretion
ISO
Benzalkonium Compounds results in increased expression of CCL2 mRNA; Benzalkonium Compounds results in increased expression of CCL2 protein Benzalkonium Compounds results in increased secretion of CCL2 protein
CTD
PMID:30171875 PMID:30517752 PMID:31707104
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
G
Ccl20
C-C motif chemokine ligand 20
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCL20 mRNA
CTD
PMID:30806763
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
G
Ccl24
C-C motif chemokine ligand 24
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CCL24 mRNA
CTD
PMID:30171875
NCBI chr12:26,737,423...26,741,420
Ensembl chr12:26,737,439...26,750,924
G
Ccl3
C-C motif chemokine ligand 3
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of CCL3 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CCL3 protein
CTD
PMID:30517752 PMID:31158415
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
G
Ccl4
C-C motif chemokine ligand 4
decreases expression increases expression multiple interactions
ISO
Benzalkonium Compounds results in decreased expression of CCL4 mRNA; Benzalkonium Compounds results in decreased expression of CCL4 protein Benzalkonium Compounds results in increased expression of CCL4 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CCL4 protein
CTD
PMID:18353026 PMID:20713136 PMID:30517752 PMID:31158415
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCL5 protein
CTD
PMID:30517752
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
G
Ccl7
C-C motif chemokine ligand 7
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCL7 mRNA; Benzalkonium Compounds results in increased expression of CCL7 protein
CTD
PMID:30171875 PMID:30517752
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CCN2 mRNA
CTD
PMID:25377654
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
G
Ccn3
cellular communication network factor 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCN3 mRNA
CTD
PMID:30171875
NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581
G
Ccr4
C-C motif chemokine receptor 4
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CCR4 mRNA
CTD
PMID:30171875
NCBI chr 8:123,054,505...123,060,244
Ensembl chr 8:123,054,324...123,077,642
G
Ccr5
C-C motif chemokine receptor 5
increases expression
ISO
Benzalkonium Compounds results in increased expression of CCR5 mRNA
CTD
PMID:30171875
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
G
Cd177
CD177 molecule
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CD177 mRNA
CTD
PMID:30171875
NCBI chr 1:89,467,926...89,488,490
Ensembl chr 1:89,467,926...89,488,443
G
Cd274
CD274 molecule
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CD274 mRNA
CTD
PMID:30171875
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951
G
Cd300c2
CD300C molecule 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of CD300C2 mRNA
CTD
PMID:30171875
NCBI chr10:100,752,301...100,757,549
Ensembl chr10:100,752,621...100,757,332
G
Cdc6
cell division cycle 6
multiple interactions decreases expression
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Benzalkonium Compounds results in decreased expression of CDC6 protein] Benzalkonium Compounds results in decreased expression of CDC6 mRNA; Benzalkonium Compounds results in decreased expression of CDC6 protein
CTD
PMID:36725023
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
G
Cfap61
cilia and flagella associated protein 61
increases expression
ISO
Benzalkonium Compounds results in increased expression of CFAP61 mRNA
CTD
PMID:31199489
NCBI chr 3:153,807,672...154,086,591
Ensembl chr 3:153,807,735...154,086,590
G
Cfd
complement factor D
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CFD mRNA
CTD
PMID:30171875
NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572
G
Chi3l1
chitinase 3 like 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of CHI3L1 mRNA
CTD
PMID:30171875
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CHRNB4 mRNA
CTD
PMID:30171875
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248
G
Cimap1d
CIMAP1 family member D
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CIMAP1D mRNA
CTD
PMID:30171875
NCBI chr 7:10,700,067...10,715,742
Ensembl chr 7:10,700,510...10,715,738
G
Clcf1
cardiotrophin-like cytokine factor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of CLCF1 mRNA
CTD
PMID:30171875
NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064
G
Cnfn
cornifelin
increases expression
ISO
Benzalkonium Compounds results in increased expression of CNFN mRNA; Benzalkonium Compounds results in increased expression of CNFN protein
CTD
PMID:25377654
NCBI chr 1:90,079,409...90,081,556
Ensembl chr 1:90,078,552...90,081,556
G
Csf1
colony stimulating factor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of CSF1 protein
CTD
PMID:30517752
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468
G
Csf2
colony stimulating factor 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of CSF2 protein
CTD
PMID:30517752
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
G
Csf3
colony stimulating factor 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of CSF3 protein
CTD
PMID:30517752
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
G
Ctps1
CTP synthase 1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CTPS1 mRNA
CTD
PMID:30171875
NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:139,410,249...139,440,465
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of CXCL10 mRNA; Benzalkonium Compounds results in increased expression of CXCL10 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CXCL10 protein
CTD
PMID:23445166 PMID:30517752 PMID:31158415
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of CXCL2 mRNA; Benzalkonium Compounds results in increased expression of CXCL2 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CXCL2 protein
CTD
PMID:30171875 PMID:30517752 PMID:31158415
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions increases expression
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CXCL3 mRNA Benzalkonium Compounds results in increased expression of CXCL1 protein; Benzalkonium Compounds results in increased expression of CXCL3 mRNA
CTD
PMID:30171875 PMID:30517752
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
G
Cxcr1
C-X-C motif chemokine receptor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of CXCR1 mRNA
CTD
PMID:30806763
NCBI chr 9:83,216,040...83,220,225
Ensembl chr 9:83,215,292...83,226,872
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
Benzalkonium Compounds results in increased expression of CXCR4 mRNA
CTD
PMID:20713136
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression increases expression
ISO
Benzalkonium Compounds results in decreased expression of CYP1A1 mRNA Benzalkonium Compounds results in increased expression of CYP1A1 mRNA
CTD
PMID:20713136 PMID:30806763
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of CYP27A1 mRNA
CTD
PMID:20713136
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
G
Cyp51
cytochrome P450, family 51
increases expression
ISO
Benzalkonium Compounds results in increased expression of CYP51 mRNA
CTD
PMID:31199489
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of DDIT3 mRNA
CTD
PMID:37149095
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
G
Dhcr24
24-dehydrocholesterol reductase
increases expression
ISO
Benzalkonium Compounds results in increased expression of DHCR24 mRNA
CTD
PMID:31199489
NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936
G
Dhcr7
7-dehydrocholesterol reductase
decreases activity increases expression
ISO
Benzalkonium Compounds results in decreased activity of DHCR7 protein Benzalkonium Compounds results in increased expression of DHCR7 mRNA
CTD
PMID:26919959
NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382
G
Dio1
iodothyronine deiodinase 1
decreases activity
ISO
Benzalkonium Compounds results in decreased activity of DIO1 protein
CTD
PMID:30561685
NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:127,303,083...127,319,771
G
Dio2
iodothyronine deiodinase 2
decreases activity
ISO
Benzalkonium Compounds results in decreased activity of DIO2 protein
CTD
PMID:30561685
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
G
Dio3
iodothyronine deiodinase 3
decreases activity
ISO
Benzalkonium Compounds results in decreased activity of DIO3 protein
CTD
PMID:30561685
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985
G
Dlk1
delta like non-canonical Notch ligand 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of DLK1 mRNA
CTD
PMID:31199489
NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of DUSP1 mRNA
CTD
PMID:30806763
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
G
Dusp10
dual specificity phosphatase 10
increases expression
ISO
Benzalkonium Compounds results in increased expression of DUSP10 mRNA
CTD
PMID:37149095
NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304
G
Ebp
EBP, cholestenol delta-isomerase
increases expression
ISO
Benzalkonium Compounds results in increased expression of EBP mRNA
CTD
PMID:26919959
NCBI chr X:16,971,372...16,977,782
Ensembl chr X:16,971,405...16,977,781
G
Egf
epidermal growth factor
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of EGF mRNA
CTD
PMID:30171875
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
G
Egr1
early growth response 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of EGR1 mRNA
CTD
PMID:25377654
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions increases phosphorylation
ISO
[Benzalkonium Compounds co-treated with G3BP1 protein] results in increased phosphorylation of EIF2AK3 protein Benzalkonium Compounds results in increased phosphorylation of EIF2AK3 protein
CTD
PMID:38734221
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases phosphorylation multiple interactions
ISO
Benzalkonium Compounds results in increased phosphorylation of EIF2S1 protein [Benzalkonium Compounds co-treated with G3BP1 protein] results in increased phosphorylation of EIF2S1 protein
CTD
PMID:38734221
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
G
Elf3
E74 like ETS transcription factor 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of ELF3 mRNA
CTD
PMID:30171875
NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380
G
Elovl1
ELOVL fatty acid elongase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ELOVL1 mRNA
CTD
PMID:29155129
NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:137,246,849...137,251,352
G
Elovl6
ELOVL fatty acid elongase 6
increases expression
ISO
Benzalkonium Compounds results in increased expression of ELOVL6 mRNA
CTD
PMID:31199489
NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549
G
Endou
endonuclease, poly(U)-specific
increases expression
ISO
Benzalkonium Compounds results in increased expression of ENDOU mRNA
CTD
PMID:30171875
NCBI chr 7:130,723,972...130,745,672
Ensembl chr 7:130,723,972...130,745,672
G
Eno1
enolase 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ENO1 mRNA
CTD
PMID:31199489
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003 Ensembl chr 5:77,946,261...77,986,003
G
Etnk1
ethanolamine kinase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ETNK1 mRNA
CTD
PMID:31199489
NCBI chr 4:177,857,001...177,901,278
Ensembl chr 4:177,856,960...177,924,721
G
Exo1
exonuclease 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of EXO1 mRNA
CTD
PMID:30171875
NCBI chr13:90,341,947...90,366,861
Ensembl chr13:90,342,018...90,366,861
G
Ezr
ezrin
increases expression
ISO
Benzalkonium Compounds results in increased expression of EZR mRNA; Benzalkonium Compounds results in increased expression of EZR protein
CTD
PMID:29893927
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573
G
Fam83a
family with sequence similarity 83, member A
increases expression
ISO
Benzalkonium Compounds results in increased expression of FAM83A mRNA
CTD
PMID:30171875
NCBI chr 7:91,412,366...91,436,819
Ensembl chr 7:91,412,366...91,436,910
G
Fgf2
fibroblast growth factor 2
affects response to substance
ISO
FGF2 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27206134
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
increases expression
ISO
Benzalkonium Compounds results in increased expression of FGR mRNA
CTD
PMID:30171875
NCBI chr 5:150,473,767...150,503,524
Ensembl chr 5:150,473,792...150,503,169
G
Flg
filaggrin
increases expression
ISO
Benzalkonium Compounds results in increased expression of FLG mRNA
CTD
PMID:30171875
NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968
G
Foxc1
forkhead box C1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXC1 mRNA
CTD
PMID:30171875
NCBI chr17:32,840,119...32,844,100
Ensembl chr17:32,805,858...32,844,347
G
Foxn1
forkhead box N1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXN1 mRNA
CTD
PMID:30171875
NCBI chr10:63,749,461...63,778,468
Ensembl chr10:63,749,461...63,771,771
G
Foxp3
forkhead box P3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXP3 mRNA
CTD
PMID:30171875
NCBI chr X:17,580,380...17,601,181
Ensembl chr X:17,580,380...17,595,894
G
G3bp1
G3BP stress granule assembly factor 1
multiple interactions
ISO
[Benzalkonium Compounds co-treated with G3BP1 protein] results in increased phosphorylation of EIF2AK3 protein; [Benzalkonium Compounds co-treated with G3BP1 protein] results in increased phosphorylation of EIF2S1 protein
CTD
PMID:38734221
NCBI chr10:40,087,533...40,120,931
Ensembl chr10:40,087,533...40,120,931
G
Gata3
GATA binding protein 3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of GATA3 mRNA
CTD
PMID:30171875
NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Benzalkonium Compounds results in increased expression of GCLC mRNA
CTD
PMID:30806763
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Benzalkonium Compounds results in increased expression of GCLM mRNA
CTD
PMID:30806763
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
G
Gpx2
glutathione peroxidase 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of GPX2 mRNA
CTD
PMID:30171875
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
G
Hbegf
heparin-binding EGF-like growth factor
increases expression
ISO
Benzalkonium Compounds results in increased expression of HBEGF mRNA
CTD
PMID:30171875
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
G
Hck
HCK proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of HCK mRNA
CTD
PMID:30171875
NCBI chr 3:162,031,833...162,074,933
Ensembl chr 3:162,031,817...162,074,935
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of HERPUD1 mRNA
CTD
PMID:37149095
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
G
Hgf
hepatocyte growth factor
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of HGF mRNA
CTD
PMID:30171875
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
ISO
Benzalkonium Compounds results in increased expression of HIF1A mRNA
CTD
PMID:30171875
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
Benzalkonium Compounds results in increased expression of HMGCR mRNA
CTD
PMID:26919959 PMID:31199489
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of HMGCS2 mRNA
CTD
PMID:31199489
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242
G
Hmox1
heme oxygenase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of HMOX1 mRNA
CTD
PMID:37149095
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Hoxa7
homeobox A7
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of HOXA7 mRNA
CTD
PMID:30171875
NCBI chr 4:82,646,342...82,652,449
Ensembl chr 4:82,646,364...82,648,241
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
increases expression
ISO
Benzalkonium Compounds results in increased expression of HSD17B7 mRNA
CTD
PMID:31199489
NCBI chr13:84,702,875...84,722,810
Ensembl chr13:84,705,631...84,722,754
G
Hspa5
heat shock protein family A (Hsp70) member 5
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of HSPA5 mRNA
CTD
PMID:28236482
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ICAM1 mRNA; Benzalkonium Compounds results in increased expression of ICAM1 protein
CTD
PMID:21742781 PMID:30806763
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Id1
inhibitor of DNA binding 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ID1 mRNA
CTD
PMID:37149095
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of IDI1 mRNA
CTD
PMID:31199489
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524
G
Ifng
interferon gamma
increases expression
ISO
Benzalkonium Compounds results in increased expression of IFNG protein
CTD
PMID:30517752
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Il10
interleukin 10
multiple interactions increases expression
ISO
Benzalkonium Compounds results in increased expression of and results in decreased secretion of IL10 protein Benzalkonium Compounds results in increased expression of IL10 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in decreased expression of IL10 protein
CTD
PMID:29953848 PMID:30517752 PMID:31158415
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
G
Il13ra2
interleukin 13 receptor subunit alpha 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL13RA2 mRNA
CTD
PMID:30171875
NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455
G
Il15
interleukin 15
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL15 protein
CTD
PMID:30517752
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348
G
Il17f
interleukin 17F
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL17F mRNA
CTD
PMID:23445166
NCBI chr 9:30,686,532...30,697,918
Ensembl chr 9:30,686,538...30,697,918
G
Il18
interleukin 18
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL18 protein Benzalkonium Compounds results in increased expression of IL18 mRNA
CTD
PMID:30517752 PMID:30806763
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
G
Il1a
interleukin 1 alpha
increases secretion increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased secretion of IL1A protein Benzalkonium Compounds results in increased expression of IL1A mRNA; Benzalkonium Compounds results in increased expression of IL1A protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL1A protein
CTD
PMID:8006454 PMID:12781210 PMID:25290854 PMID:30240708 PMID:30517752 PMID:31158415 More...
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
G
Il1b
interleukin 1 beta
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of IL1B protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL1B protein
CTD
PMID:29953848 PMID:30517752 PMID:31158415
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il1f10
interleukin 1 family member 10
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of IL1F10 mRNA
CTD
PMID:30171875
NCBI chr 3:27,470,798...27,473,726
Ensembl chr 3:27,470,798...27,473,726
G
Il23a
interleukin 23 subunit alpha
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL23A mRNA
CTD
PMID:30171875
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434
G
Il24
interleukin 24
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL24 mRNA
CTD
PMID:37149095
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760
G
Il27
interleukin 27
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL27 protein
CTD
PMID:30517752
NCBI chr 1:190,603,684...190,609,292
Ensembl chr 1:190,603,522...190,609,258
G
Il3
interleukin 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL3 protein
CTD
PMID:30517752
NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,906,460...38,908,810
G
Il31
interleukin 31
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL31 protein
CTD
PMID:30517752
NCBI chr12:38,756,231...38,765,917
Ensembl chr12:38,762,870...38,765,921
G
Il31ra
interleukin 31 receptor A
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of IL31RA mRNA
CTD
PMID:30171875
NCBI chr 2:45,851,073...45,922,300
Ensembl chr 2:45,855,868...45,917,009
G
Il34
interleukin 34
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of IL34 mRNA
CTD
PMID:30171875
NCBI chr19:55,624,368...55,690,576
Ensembl chr19:55,624,369...55,673,376
G
Il36a
interleukin 36, alpha
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL36A mRNA
CTD
PMID:30171875
NCBI chr 3:27,395,146...27,399,695
Ensembl chr 3:27,395,146...27,399,695
G
Il36b
interleukin 36, beta
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL36B mRNA
CTD
PMID:30171875
NCBI chr 3:27,422,980...27,521,344
Ensembl chr 3:27,423,171...27,428,678
G
Il36g
interleukin 36, gamma
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL36G mRNA
CTD
PMID:30171875
NCBI chr 3:27,346,675...27,352,839
Ensembl chr 3:27,346,670...27,352,834
G
Il4
interleukin 4
increases expression multiple interactions
ISO
Benzalkonium Compounds results in increased expression of IL4 protein [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in decreased expression of IL4 protein
CTD
PMID:30517752 PMID:31158415
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
G
Il5
interleukin 5
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL5 protein
CTD
PMID:30517752
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
G
Il6
interleukin 6
increases secretion increases expression multiple interactions affects response to substance
ISO
Benzalkonium Compounds results in increased secretion of IL6 protein Benzalkonium Compounds results in increased expression of IL6 mRNA Benzalkonium Compounds results in increased expression of and results in increased secretion of IL6 protein Benzalkonium Compounds results in increased expression of IL6 mRNA; Benzalkonium Compounds results in increased expression of IL6 protein IL6 protein affects the susceptibility to Benzalkonium Compounds [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of ADRA2A mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of AGTR2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of C1S2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of C3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CD177 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CD274 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CTPS1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CXCL3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CXCL5 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXC1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXN1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXP3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of GATA3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of GSDMA3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of HCK mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of HGF mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of IGHA mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of IL1F10 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRT2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP14 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP16-3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP19-2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP19-5 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP19-9B mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP6-1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP6-2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of LTB mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP25 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP9 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MRGPRA2B mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MSX2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MYLK3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of NRG2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PDCD1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PROKR2 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PTX3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of REG1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of REG3G mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of RYR1 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SAA3 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SERPINB13 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SIGLECE mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SOX21 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SRMS mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of ST14 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TFAP2B mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFRSF13C mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFRSF26 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFSF8 mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TSLP mRNA; [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of VTCN1 mRNA; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL6 protein
CTD
PMID:17763283 PMID:28214551 PMID:29953848 PMID:30171875 PMID:30517752 PMID:31158415 PMID:31707104 More...
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Il6r
interleukin 6 receptor
multiple interactions increases response to substance
ISO
[IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in decreased expression of IL10 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in decreased expression of IL4 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CCL3 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CCL4 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CXCL10 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CXCL2 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL1A protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL1B protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL22 protein; [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of IL6 protein
CTD
PMID:31158415
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
G
Il7r
interleukin 7 receptor
increases expression
ISO
Benzalkonium Compounds results in increased expression of IL7R mRNA
CTD
PMID:20713136
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027
G
Inhba
inhibin subunit beta A
increases expression
ISO
Benzalkonium Compounds results in increased expression of INHBA mRNA
CTD
PMID:30171875
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
G
Insig1
insulin induced gene 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of INSIG1 mRNA
CTD
PMID:31199489
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
G
Isl1
ISL LIM homeobox 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ISL1 mRNA
CTD
PMID:30171875
NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:49,813,618...49,823,442
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
Benzalkonium Compounds inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Benzalkonium Compounds results in decreased activity of KCNH2 protein
CTD
PMID:24052561
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
G
Kdm7a
lysine demethylase 7A
increases expression
ISO
Benzalkonium Compounds results in increased expression of KDM7A mRNA
CTD
PMID:37149095
NCBI chr 4:68,866,263...68,992,979
Ensembl chr 4:68,871,677...68,931,506
G
Kdm8
lysine demethylase 8
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of KDM8 mRNA
CTD
PMID:31199489
NCBI chr 1:189,444,527...189,459,507
Ensembl chr 1:189,444,555...189,459,491
G
Klf2
KLF transcription factor 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of KLF2 mRNA
CTD
PMID:37149095
NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,555,136...17,557,768
G
Klk8
kallikrein related-peptidase 8
increases expression
ISO
Benzalkonium Compounds results in increased expression of KLK8 mRNA
CTD
PMID:30171875
NCBI chr 1:103,388,352...103,395,195
Ensembl chr 1:103,388,352...103,395,195
G
Krt2
keratin 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRT2 mRNA
CTD
PMID:30171875
NCBI chr 7:134,819,584...134,826,736
Ensembl chr 7:134,819,584...134,827,011
G
Krtap14
keratin associated protein 14
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of KRTAP14 mRNA
CTD
PMID:30171875
NCBI chr11:41,612,876...41,613,718
Ensembl chr11:41,612,876...41,613,718
G
Lce1m
late cornified envelope 1M
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of LCE1M mRNA
CTD
PMID:30171875
NCBI chr 2:181,333,098...181,334,300
Ensembl chr 2:181,333,098...181,334,300
G
Ldha
lactate dehydrogenase A
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of LDHA mRNA
CTD
PMID:31199489
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
Benzalkonium Compounds results in increased expression of LDLR mRNA
CTD
PMID:31199489
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
Benzalkonium Compounds results in increased expression of LIF protein
CTD
PMID:30517752
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
G
LOC120097198
U6 spliceosomal RNA
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of RNU6-643P
CTD
PMID:37149095
NCBI chr15:105,897,695...105,897,798
Ensembl chr15:105,897,695...105,897,798
G
Loxl1
lysyl oxidase-like 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of LOXL1 mRNA
CTD
PMID:31199489
NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:67,587,636...67,612,224
G
Lst1
leukocyte specific transcript 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of LST1 mRNA
CTD
PMID:30171875
NCBI chr20:3,639,353...3,644,399
Ensembl chr20:3,639,341...3,642,669
G
Ltb
lymphotoxin beta
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of LTB mRNA
CTD
PMID:30171875
NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,632,210...3,634,054
G
Mapk14
mitogen activated protein kinase 14
increases phosphorylation
ISO
Benzalkonium Compounds results in increased phosphorylation of MAPK14 protein
CTD
PMID:15737199
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
G
Mesp2
mesoderm posterior bHLH transcription factor 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of MESP2 mRNA
CTD
PMID:30171875
NCBI chr 1:143,165,914...143,168,520
Ensembl chr 1:143,165,849...143,168,511
G
Mif
macrophage migration inhibitory factor
increases secretion
ISO
Benzalkonium Compounds results in increased secretion of MIF protein
CTD
PMID:31707104
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
G
Mmp10
matrix metallopeptidase 10
increases expression
ISO
Benzalkonium Compounds results in increased expression of MMP10 mRNA
CTD
PMID:30806763
NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613
G
Mmp12
matrix metallopeptidase 12
increases expression
ISO
Benzalkonium Compounds results in increased expression of MMP12 mRNA
CTD
PMID:30171875
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478
G
Mmp2
matrix metallopeptidase 2
increases activity
EXP
Benzalkonium Compounds results in increased activity of MMP2 protein
CTD
PMID:21058936
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
G
Mmp25
matrix metallopeptidase 25
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP25 mRNA
CTD
PMID:30171875
NCBI chr10:13,164,974...13,180,503
Ensembl chr10:13,164,977...13,180,503
G
Mmp9
matrix metallopeptidase 9
multiple interactions increases activity
ISO EXP
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP9 mRNA Benzalkonium Compounds results in increased activity of MMP9 protein
CTD
PMID:21058936 PMID:30171875
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
G
Msmo1
methylsterol monooxygenase 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of MSMO1 mRNA
CTD
PMID:31199489
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445
G
Msx2
msh homeobox 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MSX2 mRNA
CTD
PMID:30171875
NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945
G
Mt2
metallothionein 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of MT2 mRNA
CTD
PMID:31199489
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of MTHFD2 mRNA
CTD
PMID:31199489
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350
G
Mylk3
myosin light chain kinase 3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MYLK3 mRNA
CTD
PMID:30171875
NCBI chr19:37,858,298...37,916,805
Ensembl chr19:37,865,141...37,915,827
G
Ndufa4
Ndufa4, mitochondrial complex associated
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of NDUFA4 mRNA
CTD
PMID:31199489
NCBI chr 4:40,968,391...40,975,559
Ensembl chr 4:40,968,391...40,975,559
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of NR4A2 mRNA
CTD
PMID:25377654
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769
G
Nrg2
neuregulin 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of NRG2 mRNA
CTD
PMID:30171875
NCBI chr18:27,890,578...28,072,538
Ensembl chr18:27,890,578...28,072,538
G
Ntrk3
neurotrophic receptor tyrosine kinase 3
affects response to substance
ISO
NTRK3 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27206134
NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:141,542,569...141,913,004
G
Ocln
occludin
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of OCLN protein
CTD
PMID:29514330
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
G
Odc1
ornithine decarboxylase 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ODC1 mRNA
CTD
PMID:31199489
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
G
Olr1
oxidized low density lipoprotein receptor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of OLR1 mRNA
CTD
PMID:30171875
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598
G
Orm1
orosomucoid 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of ORM1 mRNA
CTD
PMID:30171875
NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
Benzalkonium Compounds analog results in increased cleavage of PARP1 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Benzalkonium Compounds analog results in increased cleavage of PARP1 protein]
CTD
PMID:31982400
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
G
Pbk
PDZ binding kinase
increases expression
ISO
Benzalkonium Compounds results in increased expression of PBK mRNA
CTD
PMID:30171875
NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PCSK9 mRNA
CTD
PMID:31199489
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507
G
Pdcd1
programmed cell death 1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PDCD1 mRNA
CTD
PMID:30171875
NCBI chr 9:101,866,124...101,879,278
Ensembl chr 9:101,866,126...101,879,270
G
Pfdn6
prefoldin subunit 6
affects response to substance
ISO
PFDN6 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,947,844...4,949,318
Ensembl chr20:4,947,844...4,949,318
G
Pglyrp3
peptidoglycan recognition protein 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of PGLYRP3 mRNA
CTD
PMID:30171875
NCBI chr 2:180,174,931...180,186,007
Ensembl chr 2:179,201,527...179,219,994 Ensembl chr 2:179,201,527...179,219,994
G
Pgp
phosphoglycolate phosphatase
increases expression
ISO
Benzalkonium Compounds results in increased expression of PGP mRNA
CTD
PMID:31199489
NCBI chr10:13,999,782...14,002,408
Ensembl chr10:13,999,331...14,002,408
G
Pla2g5
phospholipase A2, group V
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PLA2G5 mRNA
CTD
PMID:30171875
NCBI chr 5:156,324,628...156,393,065
Ensembl chr 5:156,324,629...156,381,926
G
Plcxd3
phosphatidylinositol-specific phospholipase C, X domain containing 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of PLCXD3 mRNA
CTD
PMID:31199489
NCBI chr 2:55,294,597...55,473,968
Ensembl chr 2:55,294,613...55,474,220
G
Plk2
polo-like kinase 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PLK2 mRNA
CTD
PMID:37149095
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296
G
Pnpla2
patatin-like phospholipase domain containing 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PNPLA2 mRNA
CTD
PMID:31199489
NCBI chr 1:205,982,279...205,987,361
Ensembl chr 1:205,982,258...205,987,359
G
Polr1d
RNA polymerase I and III subunit D
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of POLR1D mRNA
CTD
PMID:31199489
NCBI chr12:13,084,505...13,118,069
Ensembl chr12:13,084,512...13,095,627
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of PPARA mRNA
CTD
PMID:31199489
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of PRKAA2 mRNA
CTD
PMID:31199489
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324
G
Prkag2
protein kinase AMP-activated non-catalytic subunit gamma 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of PRKAG2 mRNA
CTD
PMID:31199489
NCBI chr 4:10,744,695...10,985,939
Ensembl chr 4:10,744,588...10,985,939
G
Prokr2
prokineticin receptor 2
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PROKR2 mRNA
CTD
PMID:30171875
NCBI chr 3:140,077,629...140,092,327
Ensembl chr 3:140,077,630...140,092,093
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of PTGS2 mRNA
CTD
PMID:30806763
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Ptx3
pentraxin 3
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of PTX3 mRNA
CTD
PMID:30171875
NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372
G
Ralgdsl2
ral guanine nucleotide dissociation stimulator like 2
affects response to substance
ISO
RGL2 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,950,379...4,958,315
Ensembl chr20:4,950,381...4,958,135
G
Reg1a
regenerating family member 1 alpha
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of REG1 mRNA
CTD
PMID:30171875
NCBI chr 4:112,450,466...112,453,130
Ensembl chr 4:112,450,468...112,453,585
G
Reg3g
regenerating family member 3 gamma
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of REG3G mRNA
CTD
PMID:30171875
NCBI chr 4:112,482,183...112,484,738
Ensembl chr 4:112,482,183...112,484,738
G
Rps18
ribosomal protein S18
affects response to substance
ISO
RPS18 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,933,741...4,937,423
Ensembl chr20:4,917,095...4,937,423
G
RT1-DOa
RT1 class II, locus DOa
affects response to substance
ISO
HLA-DOA SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,755,287...4,758,491
Ensembl chr20:4,755,499...4,758,478
G
RT1-DOb
RT1 class II, locus DOb
affects response to substance
ISO
HLA-DOB SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,621,336...4,627,537
Ensembl chr20:4,619,694...4,627,523
G
RT1-Ha
RT1 class II, locus Ha
affects response to substance
ISO
HLA-DPA1 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,762,425...4,772,439
Ensembl chr20:4,763,033...4,772,141
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
affects response to substance
ISO
HLA-DPB1 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,777,494...4,781,486
Ensembl chr20:4,776,547...4,781,574
G
Ryr1
ryanodine receptor 1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of RYR1 mRNA
CTD
PMID:30171875
NCBI chr 1:93,420,078...93,551,305
Ensembl chr 1:93,420,078...93,551,305
G
Scd
stearoyl-CoA desaturase
increases expression decreases expression
ISO
Benzalkonium Compounds results in increased expression of SCD mRNA Benzalkonium Compounds results in decreased expression of SCD1 mRNA
CTD
PMID:29155129 PMID:31199489
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
G
Serpinb13
serpin family B member 13
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SERPINB13 mRNA
CTD
PMID:30171875
NCBI chr13:23,633,220...23,665,100
Ensembl chr13:23,633,220...23,664,994
G
Serpine1
serpin family E member 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of SERPINE1 mRNA
CTD
PMID:30171875
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
G
Sesn2
sestrin 2
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of SESN2 mRNA
CTD
PMID:31199489
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
G
Sfn
stratifin
increases expression
ISO
Benzalkonium Compounds results in increased expression of SFN mRNA
CTD
PMID:30171875
NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995
G
Sfrp4
secreted frizzled-related protein 4
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of SFRP4 mRNA
CTD
PMID:30171875
NCBI chr17:49,974,532...50,026,448
Ensembl chr17:50,015,812...50,026,395
G
Slc16a1
solute carrier family 16 member 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of SLC16A1 mRNA
CTD
PMID:31199489
NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:194,812,502...194,832,977
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Benzalkonium Compounds results in increased expression of SLC7A11 mRNA
CTD
PMID:30806763 PMID:37149095
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
G
Snora38
small nucleolar RNA, H/ACA box 38
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of SNORA38
CTD
PMID:37149095
NCBI chr 9:22,077,872...22,077,996
G
Snora71d
small nucleolar RNA, H/ACA box 71D
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of SNORA71D mRNA
CTD
PMID:25377654
NCBI chr 1:241,544,327...241,544,458
Ensembl chr 1:241,544,327...241,544,458
G
Sox21
SRY-box transcription factor 21
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SOX21 mRNA
CTD
PMID:30171875
NCBI chr15:101,699,580...101,703,175
Ensembl chr15:101,674,512...101,819,980
G
Sprr1a
small proline-rich protein 1A
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR1A mRNA
CTD
PMID:30171875
NCBI chr 2:180,750,709...180,752,625
Ensembl chr 2:180,750,709...180,752,991
G
Sprr1b
small proline-rich protein 1B
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR1B mRNA
CTD
PMID:30171875
NCBI chr 2:180,704,457...180,706,355
Ensembl chr 2:180,704,457...180,706,355
G
Sprr2a
small proline rich protein 2A
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR2H mRNA
CTD
PMID:30171875
NCBI chr 2:180,511,568...180,511,840
G
Sprr2b
small proline rich protein 2B
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR2B mRNA
CTD
PMID:30171875
NCBI chr 2:180,548,428...180,548,700
G
Sprr2f
small proline rich protein 2F
increases expression
ISO
Benzalkonium Compounds results in increased expression of SPRR2F mRNA
CTD
PMID:30171875
NCBI chr 2:180,685,587...180,685,817
Ensembl chr 2:180,685,587...180,685,817
G
Sqle
squalene epoxidase
increases expression
ISO
Benzalkonium Compounds results in increased expression of SQLE mRNA
CTD
PMID:31199489
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
G
Srebf2
sterol regulatory element binding transcription factor 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of SREBF2 mRNA
CTD
PMID:26919959
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943
G
Srms
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SRMS mRNA
CTD
PMID:30171875
NCBI chr 3:188,696,070...188,702,474
Ensembl chr 3:188,696,071...188,702,474
G
St14
ST14 transmembrane serine protease matriptase
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of ST14 mRNA
CTD
PMID:30171875
NCBI chr 8:37,798,994...37,839,881
Ensembl chr 8:37,798,995...37,855,652
G
Tapbp
TAP binding protein
affects response to substance
ISO
TAPBP SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,958,821...4,967,958
Ensembl chr20:4,959,926...4,971,834
G
Tfap2b
transcription factor AP-2 beta
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TFAP2B mRNA
CTD
PMID:30171875
NCBI chr 9:29,282,703...29,312,568
Ensembl chr 9:29,282,825...29,312,568
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of TGFB1 protein
CTD
PMID:30517752
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
G
Tgm3
transglutaminase 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of TGM3 mRNA
CTD
PMID:30171875
NCBI chr 3:137,681,809...137,717,219
Ensembl chr 3:137,681,809...137,717,219
G
Tgm7
transglutaminase 7
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of TGM7 mRNA
CTD
PMID:30171875
NCBI chr 3:128,505,638...128,523,298
Ensembl chr 3:128,505,650...128,529,939
G
Thbs1
thrombospondin 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of THBS1 mRNA
CTD
PMID:30171875
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
G
Tlr1
toll-like receptor 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of TLR1 mRNA
CTD
PMID:30171875
NCBI chr14:43,737,761...43,750,389
Ensembl chr14:43,740,379...43,756,243
G
Tlr4
toll-like receptor 4
increases activity
ISO
Benzalkonium Compounds results in increased activity of TLR4 protein
CTD
PMID:29514330
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
G
Tmprss11b
transmembrane serine protease 11B
increases expression
ISO
Benzalkonium Compounds results in increased expression of TMPRSS11B mRNA
CTD
PMID:30171875
NCBI chr14:21,738,760...21,763,896
Ensembl chr14:21,738,760...21,762,107
G
Tnf
tumor necrosis factor
decreases secretion increases expression
ISO
Benzalkonium Compounds results in decreased secretion of TNF protein Benzalkonium Compounds results in increased expression of TNF mRNA; Benzalkonium Compounds results in increased expression of TNF protein
CTD
PMID:29953848 PMID:30171875 PMID:30517752
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tnfaip6
TNF alpha induced protein 6
increases expression
ISO
Benzalkonium Compounds results in increased expression of TNFAIP6 mRNA
CTD
PMID:30171875
NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796
G
Tnfrsf13c
TNF receptor superfamily member 13C
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFRSF13C mRNA
CTD
PMID:30171875
NCBI chr 7:115,616,139...115,618,647
Ensembl chr 7:115,616,303...115,618,620
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
Benzalkonium Compounds results in increased expression of TNFRSF9 mRNA
CTD
PMID:30171875
NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:166,664,494...166,690,831
G
Tnfsf8
TNF superfamily member 8
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TNFSF8 mRNA
CTD
PMID:30171875
NCBI chr 5:82,266,436...82,292,858
Ensembl chr 5:82,266,436...82,292,858
G
Tp53
tumor protein p53
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of TP53 mRNA
CTD
PMID:28236482
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
G
Tpi1
triosephosphate isomerase 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of TPI1 mRNA
CTD
PMID:31199489
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:159,301,562...159,305,413
G
Trem2
triggering receptor expressed on myeloid cells 2
increases expression
ISO
Benzalkonium Compounds results in increased expression of TREM2 mRNA
CTD
PMID:30171875
NCBI chr 9:20,145,215...20,151,797
Ensembl chr 9:20,144,334...20,151,779
G
Trib3
tribbles pseudokinase 3
increases expression
ISO
Benzalkonium Compounds results in increased expression of TRIB3 mRNA
CTD
PMID:37149095
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
G
Tslp
thymic stromal lymphopoietin
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TSLP mRNA
CTD
PMID:30171875
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,720,257...24,728,420
G
Ulbp1
UL16 binding protein 1
increases expression
ISO
Benzalkonium Compounds results in increased expression of ULBP1 mRNA
CTD
PMID:37149095
NCBI chr 1:3,506,106...3,527,982
G
Upk3b
uroplakin 3B
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of UPK3B mRNA
CTD
PMID:30171875
NCBI chr12:26,266,838...26,274,240
Ensembl chr12:26,266,838...26,274,240
G
Uqcrq
ubiquinol-cytochrome c reductase, complex III subunit VII
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of UQCRQ mRNA
CTD
PMID:31199489
NCBI chr10:38,086,691...38,093,871
Ensembl chr10:38,087,715...38,089,996
G
Vegfd
vascular endothelial growth factor D
increases expression
ISO
Benzalkonium Compounds results in increased expression of VEGFD mRNA
CTD
PMID:20146380
NCBI chr X:33,704,582...33,740,305
Ensembl chr X:33,706,055...33,740,167
G
Vtcn1
V-set domain containing T cell activation inhibitor 1
multiple interactions
ISO
[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of VTCN1 mRNA
CTD
PMID:30171875
NCBI chr 2:190,942,224...191,010,280
Ensembl chr 2:190,942,224...191,010,280
G
Wdr46
WD repeat domain 46
affects response to substance
ISO
WDR46 SNP affects the susceptibility to Benzalkonium Compounds
CTD
PMID:27258892
NCBI chr20:4,939,721...4,947,619
Ensembl chr20:4,939,732...4,947,741
G
Xbp1
X-box binding protein 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of XBP1 mRNA alternative form
CTD
PMID:28236482
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
G
Xcl1
X-C motif chemokine ligand 1
decreases expression
ISO
Benzalkonium Compounds results in decreased expression of XCL1 mRNA
CTD
PMID:30171875
NCBI chr13:79,781,784...79,785,440
Ensembl chr13:79,781,784...79,785,440
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all